Swarajya

Our View
MagazineHeadlinesVideosBooksस्वराज्यEconomyCultureEvents
User Profile
Subscribe
Swarajya
Subscribe
  • Our View
  • Headlines
  • Magazine
Swarajya
  • Politics
  • Economics
  • Business
  • Culture
  • Books & Ideas
  • World
  • Defence
  • Energy & Infrastructure
  • Science
  • Technology
  • Heritage
  • Videos
  • Archives
  • Blogs
  • News Brief
  • Subscriber login
  • Politics
  • Economics
  • Business
  • Culture
  • Books & Ideas
  • World
  • Defence
  • Energy & Infrastructure
  • Science
  • Technology
  • Heritage
  • Videos
  • Archives
  • Blogs
  • News Brief

Johnson & Johnson

Johnson & Johnson Announces Separation Of Businesses: Details You Need To Know
Johnson & Johnson Announces Separation Of Businesses: Details You Need To KnowBhaswati Guha Majumder Nov 15, 2021 11:06 AM +05:30 IST
AHPI Close To Striking A Deal For Import Of J&J's Single-Dose COVID-19 Vaccine Into India Early Next Month
AHPI Close To Striking A Deal For Import Of J&J's Single-Dose COVID-19 Vaccine Into India Early Next MonthSwarajya StaffJun 26, 2021 01:53 PM +05:30 IST
India In Discussions With Pfizer, J&J Over Possible Local Manufacturing Of Their Covid Vaccines
India In Discussions With Pfizer, J&J Over Possible Local Manufacturing Of Their Covid VaccinesSwarajya StaffJun 3, 2021 07:13 PM +05:30 IST
Prefer Dealing With Centre Directly Instead Of States, Private Players For Covid-19 Jabs: Pfizer, Moderna
Prefer Dealing With Centre Directly Instead Of States, Private Players For Covid-19 Jabs: Pfizer, ModernaSwarajya StaffMay 24, 2021 02:53 PM +05:30 IST
S Jaishankar To Visit US Next Week To Seal Deals On Covid-19 Vaccine Supplies
S Jaishankar To Visit US Next Week To Seal Deals On Covid-19 Vaccine SuppliesSwarajya StaffMay 22, 2021 05:04 PM +05:30 IST
J&J Plans To Conduct Bridging Trials Of Its Covid Vaccine In India, Awaits DCGI Nod: Report
J&J Plans To Conduct Bridging Trials Of Its Covid Vaccine In India, Awaits DCGI Nod: ReportSwarajya StaffMay 14, 2021 02:30 PM +05:30 IST
J&J's Single-Dose Covid-19 Vaccine Likely To Be Imported To India By June-July: DBT Secretary Renu Swarup
J&J's Single-Dose Covid-19 Vaccine Likely To Be Imported To India By June-July: DBT Secretary Renu SwarupSwarajya StaffApr 23, 2021 09:10 AM +05:30 IST
J&J Seeks Indian Drug Regulator's Nod For Phase 3 Trials Of Its Single-Dose COVID-19 Vaccine, Import License: Report
J&J Seeks Indian Drug Regulator's Nod For Phase 3 Trials Of Its Single-Dose COVID-19 Vaccine, Import License: ReportSwarajya StaffApr 20, 2021 08:31 AM +05:30 IST
US: Johnson & Johnson Halts Shipment of 15 Million COVID Vaccine As Factory Workers Accidentally Conflated Ingredients Of 2 Different Vaccines
US: Johnson & Johnson Halts Shipment of 15 Million COVID Vaccine As Factory Workers Accidentally Conflated Ingredients Of 2 Different Vaccines Swarajya StaffApr 1, 2021 04:38 PM +05:30 IST
Johnson & Johnson's Single-Dose COVID-19 Vaccine Approved For Use In European Union
Johnson & Johnson's Single-Dose COVID-19 Vaccine Approved For Use In European UnionSwarajya StaffMar 12, 2021 11:04 AM +05:30 IST
India To Make J&J's Single-Dose COVID-19 Vaccine Under Quad Initiative To Help Countries In Indo-Pacific Region: Report
India To Make J&J's Single-Dose COVID-19 Vaccine Under Quad Initiative To Help Countries In Indo-Pacific Region: ReportSwarajya StaffMar 12, 2021 10:01 AM +05:30 IST
US FDA Clears Johnson & Johnson's Single-Dose COVID Vaccine; J&J To Produce A Billion Doses By End Of Year
US FDA Clears Johnson & Johnson's Single-Dose COVID Vaccine; J&J To Produce A Billion Doses By End Of YearSwarajya StaffFeb 28, 2021 12:37 PM +05:30 IST
Novavax, J&J Covid-19 Vaccines Show Encouraging Results In Phase 3 Trials
Novavax, J&J Covid-19 Vaccines Show Encouraging Results In Phase 3 TrialsSwarajya StaffJan 30, 2021 02:34 PM +05:30 IST
Johnson and Johnson's Single-Dose COVID-19 Vaccine Candidate Elicits Strong Immune Response In Phase 1 And 2 Trials
Johnson and Johnson's Single-Dose COVID-19 Vaccine Candidate Elicits Strong Immune Response In Phase 1 And 2 TrialsSwarajya StaffJan 15, 2021 08:51 AM +05:30 IST
Johnson & Johnson Temporarily Pauses Covid-19 Vaccine Trials Due To 'Unexplained' Illness In Study Participant
Johnson & Johnson Temporarily Pauses Covid-19 Vaccine Trials Due To 'Unexplained' Illness In Study ParticipantSwarajya StaffOct 13, 2020 08:59 AM +05:30 IST
Coronavirus: Johnson & Johnson to Begin Human Trial Of Covid-19 Vaccine In July  
Coronavirus: Johnson & Johnson to Begin Human Trial Of Covid-19 Vaccine In July  IANSJun 11, 2020 10:05 AM +05:30 IST
After HUL, Tax Department Opens Investigations Against Samsung, J&J For Profiteering From GST Rate Cuts
After HUL, Tax Department Opens Investigations Against Samsung, J&J For Profiteering From GST Rate CutsSwarajya StaffApr 26, 2019 11:49 AM +05:30 IST
Double Trouble For Johnson & Johnson: After Asbestos Panic, Now It’s Faulty Hip Transplants
Double Trouble For Johnson & Johnson: After Asbestos Panic, Now It’s Faulty Hip TransplantsSwarajya StaffMar 11, 2019 10:37 AM +05:30 IST
Load More

About Swarajya

Swarajya - a big tent for liberal right of centre discourse that reaches out, engages and caters to the new India.

editor@swarajyamag.com

Useful Links

  • About Us
  • Subscriptions Support
  • Editorial Philosophy
  • Press Kit
  • Fact Check
  • Gift Swarajya
  • Privacy Policy
  • Terms of Use
  • Code of Conduct
  • Plagiarism Policy
  • Refund & Cancellation Policy

Participate

  • Contact Us
  • Write for us
  • Style Guide
  • Advertise
  • Jobs

Stay Connected

  • Artboard 2 Copy 6Created with Sketch.Artboard 2 Copy 10Created with Sketch.Artboard 2 Copy 7Created with Sketch.Artboard 2 Copy 9Created with Sketch.
Copyright: Swarajya. All Rights Reserved.
Powered by Quintype